Microencapsulated Beadlets: A Comprehensive Review
Abstract
Microencapsulated beadlets are versatile multiparticulate drug delivery systems designed to incorporate active pharmaceutical ingredients within polymeric matrices, core–shell structures, or functional coatings to achieve improved stability and controlled drug release. These systems combine the advantages of microencapsulation with the flexibility of multiparticulate dosage forms and can be formulated to provide immediate, sustained, delayed, pulsatile, biphasic, or site-specific drug delivery. The present review provides a comprehensive overview of the formulation strategies, preparation techniques, characterization, evaluation, and pharmaceutical applications of microencapsulated beadlets. Various manufacturing methods, including solvent evaporation, coacervation-phase separation, fluid-bed coating, extrusion–spheronization, ionotropic gelation, spray drying, spray congealing, melt-based processes, microfluidics, and electrohydrodynamic atomization, are discussed. Particular emphasis is given to the selection and role of natural, semi-synthetic, synthetic, and biodegradable polymers in controlling drug loading, encapsulation efficiency, particle morphology, mechanical strength, and release behavior. Critical quality attributes, including particle size, size distribution, sphericity, surface morphology, density, porosity, drug content, encapsulation efficiency, swelling behavior, drug–polymer compatibility, solid-state properties, and in vitro drug release, are reviewed. Drug release mechanisms involving diffusion, swelling, erosion, dissolution, pore-mediated transport, and polymer degradation are also examined. Microencapsulated beadlets offer significant advantages, including improved patient compliance, flexible dosing, reduced dosing frequency, enhanced stability, taste masking, and the ability to combine different release profiles within a single dosage form. Despite challenges related to manufacturing reproducibility, scale-up, coating uniformity, and process control, emerging technologies such as quality-by-design, continuous manufacturing, advanced polymeric materials, and microfluidics are expected to further enhance their pharmaceutical applications.
Keywords: Microencapsulation; beadlets; microbeads; microspheres; multiparticulate drug delivery; controlled release.
Keywords:
Microencapsulation, beadlets, microbeads, microspheres, multiparticulate drug delivery, controlled releaseDOI
https://doi.org/10.22270/jddt.v16i10.8015References
1. Singh MN, Hemant KSY, Ram M, Shivakumar HG. “Microencapsulation: a promising technique for controlled drug delivery” Res Pharm Sci., 2010;5(2):65-77.
2. Kállai-Szabó N, Farkas D, Lengyel M, Basa B, Fleck C, Antal I. “Microparticles and multi-unit systems for advanced drug delivery” European Journal of Pharmaceutical Sciences, 2024;194:106704. https://doi.org/10.1016/j.ejps.2024.106704 PMid:38228279
3. Bale S, Khurana A, Reddy ASS, Singh M, Godugu C. “Overview on therapeutic applications of microparticulate drug delivery systems” Crit Rev Ther Drug Carrier Syst., 2016;33(4):309-361. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2016015798 PMid:27910739
4. Dasan KP, Rekha C. “Polymer blend microspheres for controlled drug release: the techniques for preparation and characterization: a review article” Curr Drug Deliv., 2012;9(6):588-595. https://doi.org/10.2174/156720112803529783 PMid:22780912
5. Yan C, Kim SR. “Microencapsulation for pharmaceutical applications: a review” ACS Appl Bio Mater, 2024;7(2):692-710. https://doi.org/10.1021/acsabm.3c00776 PMid:38320297
6. Munday DL. “Extrusion and spheronization in the development of oral controlled-release dosage forms” Pharm Sci Technol Today, 1999;2(4):160-170. https://doi.org/10.1016/S1461-5347(99)00136-4 PMid:10322373
7. Freitas S, Merkle HP, Gander B. “Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology” J Control Release, 2005;102(2):313-332. https://doi.org/10.1016/j.jconrel.2004.10.015 PMid:15653154
8. Yan C, Kim SR. “Microencapsulation for pharmaceutical applications: a review” ACS Appl Bio Mater, 2024;7(2):692-710. https://doi.org/10.1021/acsabm.3c00776 PMid:38320297
9. Munday DL. “Extrusion and spheronization in the development of oral controlled-release dosage forms” Pharm Sci Technol Today, 1999;2(4):160-170. https://doi.org/10.1016/S1461-5347(99)00136-4 PMid:10322373
10. Ramazani F, Chen W, Van Nostrum CF, Storm G, Kiessling F, Lammers T, Hennink WE, Kok RJ. “Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges” International journal of pharmaceutics, 2016;499(1-2):358-367. https://doi.org/10.1016/j.ijpharm.2016.01.020 PMid:26795193
11. Freitas S, Merkle HP, Gander B. “Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology” J Control Release, 2005;102(2):313-332. https://doi.org/10.1016/j.jconrel.2004.10.015 PMid:15653154
12. Su W, Wang D, Yeboah S, Wang J, Xu C, Wang L. “Microencapsulation and characterization of controlled-release intestinal drugs: a critical review, Journal of Zhejiang University-SCIENCE , 2026;27(4):321-342. https://doi.org/10.1631/jzus.B2400617 PMid:42046868 PMCid:PMC13121888
13. Freitas S, Merkle HP, Gander B. “Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology”. J Control Release, 2005;102(2):313-332. https://doi.org/10.1016/j.jconrel.2004.10.015 PMid:15653154
14. Li M, Rouaud O, Poncelet D. “Microencapsulation by solvent evaporation: state of the art for process engineering approaches” Int J Pharm, 2008;363(1-2):26-39. https://doi.org/10.1016/j.ijpharm.2008.07.018 PMid:18706988
15. Lu Y, Park K. “Microencapsulation: methods and pharmaceutical applications. in: J. Swarbrick (Ed.), Encyclopedia of Pharmaceutical Science and Technology, 2012;1:1-3.
16. Jyothi NVN, Prasanna PM, Sakarkar SN, Prabha KS, Ramaiah PS, Srawan GY. “Microencapsulation techniques, factors influencing encapsulation efficiency” J Microencapsul, 2010;27(3):187-197. https://doi.org/10.3109/02652040903131301 PMid:20406093
17. Gouin S. “Microencapsulation: industrial appraisal of existing technologies and trends” Trends Food Sci Technol, 2004;15:330-347. https://doi.org/10.1016/j.tifs.2003.10.005
18. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs, J Control Release, 2006;114:1-14. https://doi.org/10.1016/j.jconrel.2006.04.017 PMid:16828914
19. Anal AK, Stevens WF. “Chitosan-alginate multilayer beads for controlled release of protein” Int J Pharm. 2005;290:45-54. https://doi.org/10.1016/j.ijpharm.2004.11.015 PMid:15664129
20. Hari PR, Chandy T, Sharma CP. “Chitosan/calcium-alginate beads for oral delivery of insulin” J Appl Polym Sci. 1996;59:1795-1801. https://doi.org/10.1002/(SICI)1097-4628(19960314)59:11<1795::AID-APP16>3.0.CO;2-T
21. Nussinovitch A. Beads as drug carriers. In Polymer macro-and micro-gel beads: fundamentals and applications 2010 Aug 17 (pp. 191-230). New York, NY: Springer New York. https://doi.org/10.1007/978-1-4419-6618-6_8
22. Gombotz WR, Wee SF. “Protein release from alginate matrices” Adv Drug Deliv Rev., 1998;31:267-285. https://doi.org/10.1016/S0169-409X(97)00124-5 PMid:10837629
23. Smidsrød O, Skjåk-Bræk G. “Alginate as immobilization matrix for cells” Trends Biotechnol., 1990;8:71-78. https://doi.org/10.1016/0167-7799(90)90139-O PMid:1366500
24. Freitas S, Merkle HP, Gander B. “Microencapsulation by solvent extraction/evaporation”: reviewing the state of the art of microsphere preparation process technology. J Control Release., 2005;102(2):313-332. https://doi.org/10.1016/j.jconrel.2004.10.015 PMid:15653154
25. Li M, Rouaud O, Poncelet D. “Microencapsulation by solvent evaporation: state of the art for process engineering approaches, Int J Pharm. 2008;363(1-2):26-39. https://doi.org/10.1016/j.ijpharm.2008.07.018 PMid:18706988
26. Vervaet C, Baert L, Remon JP. “Extrusion-spheronisation: a literature review” Int J Pharm, 1995;116:131-146. https://doi.org/10.1016/0378-5173(94)00311-R
27. Dukić-Ott A, Thommes M, Remon JP, Kleinebudde P, Vervaet C. “Production of pellets via extrusion-spheronisation without incorporation of microcrystalline cellulose: a critical review” Eur J Pharm Biopharm. 2009;71(1):38-46. https://doi.org/10.1016/j.ejpb.2008.08.005 PMid:18771727
28. Muley S, Nandgude T, Poddar S. “Extrusion-spheronization a promising pelletization technique: In-depth review” Asian journal of pharmaceutical sciences. 2016 1;11(6):684-699. https://doi.org/10.1016/j.ajps.2016.08.001
29. Ghai D. “Extrusion and spheronization in the development of oral controlled-release dosage forms” Pharm Sci Technol Today, 1999;2(4):160-170. https://doi.org/10.1016/S1461-5347(99)00136-4 PMid:10322373
30. Kleinebudde P. “The crystallite-gel model for microcrystalline cellulose in extrusion-spheronization” Pharm Res. 1997;14:804-809. https://doi.org/10.1023/A:1012166809583 PMid:9210201
31. Fielden KE, Newton JM, O’Brien P, Rowe RC. “Thermal studies on the interaction between water and microcrystalline cellulose”. J Pharm Pharmacol., 1988;40:674-678. https://doi.org/10.1111/j.2042-7158.1988.tb06993.x PMid:2907531
32. Wan LSC, Heng PWS, Liew CV. “Spheronization conditions on spheroid shape and size” Int J Pharm. 1993;96:59-65. https://doi.org/10.1016/0378-5173(93)90212-X
33. Vertommen J, Kinget R. “The influence of five selected processing variables on pellet distribution, surface area, porosity and hardness” Int J Pharm., 1997;153:135-145.
34. Mehta AM. Fluid bed processing: principles and applications. Pharm Technol. 2003;27:62-76.
35. Porter SC. “Fluid-bed processing: coating and granulation” Pharm Technol., 2002;26:44-58.
36. Jones DM. Film coating of multiparticulate systems. Drug Dev Ind Pharm. 2001;27:571-579.
37. Felton LA. “Film coating of oral solid dosage forms” AAPS PharmSciTech. 2013;14:1213-1223.
38. Ghebre-Sellassie I. “Pellets: a general overview” In: Ghebre-Sellassie I, ed. Pharmaceutical Pelletization Technology New York: Marcel Dekker; 1989.
39. Rowe RC. “The adhesion of film coatings to tablet surfaces” J Pharm Pharmacol. 1980;32:501-505. https://doi.org/10.1111/j.2042-7158.1980.tb12893.x PMid:6103940
40. Bodmeier R, Paeratakul O. “The drug release from microparticles prepared by a modified solvent evaporation method” J Microencapsul. 1990;7(4):527-537.
41. Wada R, Hyon SH, Ikada Y.” Preparation of biodegradable microspheres” J Pharm Sci. 1991;80:1117-1122.
42. O’Donnell PB, McGinity JW. “Preparation of microspheres by the solvent evaporation technique” Adv Drug Deliv Rev. 1997;28:25-42. https://doi.org/10.1016/S0169-409X(97)00049-5 PMid:10837563
43. Arshady R. “Preparation of biodegradable microspheres and microcapsules” J Control Release. 1991;17:1-22. https://doi.org/10.1016/0168-3659(91)90126-X
44. Aulton ME, Taylor KMG. Aulton’s pharmaceutics: the design and manufacture of medicines. 6th ed. London: Elsevier; 2022.
45. Allen LV Jr. Ansel’s pharmaceutical dosage forms and drug delivery systems. 11th ed. Philadelphia: Wolters Kluwer; 2020.
46. Benita S, editor. Microencapsulation: methods and industrial applications. 2nd ed. Boca Raton: CRC Press; 2006.
47. Nandiyanto ABD, Okuyama K. “Progress in developing a simple and rapid method for the production of controlled morphology particles” Adv Powder Technol. 2011;22(1):1-19. https://doi.org/10.1016/j.apt.2010.09.011
48. Jyothi NVN, Prasanna PM, Sakarkar SN, Prabha KS, Ramaiah PS, Srawan GY. “Microencapsulation techniques, factors influencing encapsulation efficiency” J Microencapsul. 2010;27(3):187-197. https://doi.org/10.3109/02652040903131301 PMid:20406093
49. Soppimath KS, Kulkarni AR, Aminabhavi TM. “Development of hollow microspheres as floating controlled-release systems for cardiovascular drugs: preparation and release characteristics” Drug Dev Ind Pharm. 2001;27(6):507-515. https://doi.org/10.1081/DDC-100105175 PMid:11548857
50. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm. 2004;282(1-2):1-18. https://doi.org/10.1016/j.ijpharm.2004.04.013 PMid:15336378
51. George M, Abraham TE. “Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review” J Control Release. 2006;114(1):1-14. https://doi.org/10.1016/j.jconrel.2006.04.017 PMid:16828914
52. Müller RH, Jacobs C, Kayser O. “Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future” Adv Drug Deliv Rev. 2001;47(1):3-19. https://doi.org/10.1016/S0169-409X(00)00118-6 PMid:11251242
53. Stuart B. Infrared spectroscopy: fundamentals and applications. Chichester: Wiley; 2004. https://doi.org/10.1002/0470011149
54. Craig DQM, Reading M, editors. Thermal analysis of pharmaceuticals. Boca Raton: CRC Press; 2007. https://doi.org/10.1201/9781420014891
55. Yu L. “Amorphous pharmaceutical solids: preparation, characterization and stabilization” Adv Drug Deliv Rev. 2001;48(1):27-42. https://doi.org/10.1016/S0169-409X(01)00098-9 PMid:11325475
56. Siepmann J, Peppas NA. “Higuchi equation: derivation, applications, use and misuse” Int J Pharm. 2011;418(1):6-12. https://doi.org/10.1016/j.ijpharm.2011.03.051 PMid:21458553
57. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. “Mechanisms of solute release from porous hydrophilic polymers” Int J Pharm. 1983;15(1):25-35. https://doi.org/10.1016/0378-5173(83)90064-9
58. International Council for Harmonisation. ICH harmonised tripartite guideline Q1A(R2): stability testing of new drug substances and products. Geneva: ICH; 2003.
59. Omeprazole delayed-release capsules;2009. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b43f6b44-9de3-4efb-a467-487aee28f6a0.Accessed Augest 25,2026.
60. Lansoprazoledelayed-releasecapsules;2025.Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e246e79-2737-4cbb-ad5d-4e76893da3be.Accessed Augest 25,2026.
61. Esomeprazole magnesium delayed-release capsules;2025.Available at: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e04e7c84-59c8-4a1d-8dfc-d72588b97b59 Bethesda (MD): National Library of Medicine; Accessed Augest 25,2026.
62. Pilbrant Å, Cederberg C., “Development of an oral formulation of omeprazole” Scand J Gastroenterol Suppl. 1985;108:113-20. https://doi.org/10.3109/00365528509095824 PMid:3858973
63. Vervaet C, Baert L, Remon JP, “Extrusion-spheronisation: a literature review” Int J Pharm. 1995;116(2):131-146. https://doi.org/10.1016/0378-5173(94)00311-R
64. Layer P, Keller J, “Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease” J Clin Gastroenterol” 1999;28(1):3-10. https://doi.org/10.1097/00004836-199901000-00002 PMid:9916657
65. Ghebre-Sellassie I, editor. Pharmaceutical pelletization technology. New York: Marcel Dekker; 1989.
66. Ghebre-Sellassie I, Knoch A. Pelletization techniques. In: Ghebre-Sellassie I, editor. Pharmaceutical pelletization technology. New York: Marcel Dekker; 1989.
67. Vyas SP, Khar RK. Controlled drug delivery: concepts and advances. New Delhi: Vallabh Prakashan; 2012.
68. Jyothi NVN, Prasanna PM, Sakarkar SN, Prabha KS, Ramaiah PS, Srawan GY., “Microencapsulation techniques, factors influencing encapsulation efficiency” J Microencapsul. 2010;27(3):187-97. https://doi.org/10.3109/02652040903131301 PMid:20406093
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Bhav Saraswat , Jyoti Gupta , Rambabu Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.